3-Pyridinecarboxylicacid, 1,1',1'',1'''-[(2-hydroxy-1,3-cyclohexanediylidene)tetrakis(methylene)]ester cas no:27959-26-8
Synonyms: 3-Pyridinecarboxylicacid, (2-hydroxy-1,3-cyclohexanediylidene)tetrakis(methylene) ester (9CI);Nicotinic acid, 1,1,3,3-tetraester with2-hydroxy-1,1,3,3-cyclohexanetetramethanol (7CI,8CI);1,1,3,3-Cyclohexanetetramethanol, 2-hydroxy-, 1,1,3,3-tetranicotinate (8CI);2,2,6,6-Tetrakis(nicotinoyloxymethyl)cyclohexanol; Cholexamine; K 31; K 31(pharmaceutical); Nicomol
Name3-Pyridinecarboxylicacid, 1,1',1'',1'''-[(2-hydroxy-1,3-cyclohexanediylidene)tetrakis(methylene)]ester
CAS27959-26-8
Synonyms3-Pyridinecarboxylicacid, (2-hydroxy-1,3-cyclohexanediylidene)tetrakis(methylene) ester (9CI);Nicotinic acid, 1,1,3,3-tetraester with2-hydroxy-1,1,3,3-cyclohexanetetramethanol (7CI,8CI);1,1,3,3-Cyclohexanetetramethanol, 2-hydroxy-, 1,1,3,3-tetranicotinate (8CI);2,2,6,6-Tetrakis(nicotinoyloxymethyl)cyclohexanol; Cholexamine; K 31; K 31(pharmaceutical); Nicomol
EINECS(EC#)248-748-9
Molecular FormulaC34H32 N4 O9
Molecular Weight640.70
refractive index1.596
Safety
Mildly toxic by ingestion. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. An anticholesteremic agent that reduces the blood cholesterol level. See also ESTERS.
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intraperitoneal |
> 14700mg/kg (14700mg/kg) |
|
Oyo Yakuri. Pharmacometrics. Vol. 2, Pg. 237, 1968. |
mouse |
LD50 |
oral |
> 17800mg/kg (17800mg/kg) |
|
Oyo Yakuri. Pharmacometrics. Vol. 2, Pg. 237, 1968. |
mouse |
LD50 |
subcutaneous |
> 3gm/kg (3000mg/kg) |
|
Oyo Yakuri. Pharmacometrics. Vol. 2, Pg. 237, 1968. |
rat |
LD20 |
intraperitoneal |
> 2500mg/kg (2500mg/kg) |
|
Oyo Yakuri. Pharmacometrics. Vol. 14(5), Pg. 741, 1977. |
rat |
LD50 |
oral |
10gm/kg (10000mg/kg) |
|
Oyo Yakuri. Pharmacometrics. Vol. 14, Pg. 741, 1977. |
rat |
LD50 |
subcutaneous |
> 3gm/kg (3000mg/kg) |
|
Oyo Yakuri. Pharmacometrics. Vol. 2, Pg. 237, 1968. |